Back to Search Start Over

Avastin breast cancer blip: time to buy, analyst says

Authors :
Osborne, Randall
Source :
Bioworld Financial Watch. Sept 18, 2006, Vol. 14 Issue 38, p1, 3 p.
Publication Year :
2006

Abstract

Already getting the colloquial hairy eyeball from some observers because of slowed (though still strong) sales, Avastin stumbled further last week on news that the FDA wants more information about [...]

Subjects

Subjects :
Genentech Inc. -- Product development
Biological products industry -- Product development
Antimitotic agents -- Licensing, certification and accreditation
Antineoplastic agents -- Licensing, certification and accreditation
Banking, finance and accounting industries
Biotechnology industry
Avastin (Medication) -- Licensing, certification and accreditation

Details

Language :
English
ISSN :
15410579
Volume :
14
Issue :
38
Database :
Gale General OneFile
Journal :
Bioworld Financial Watch
Publication Type :
News
Accession number :
edsgcl.151905183

Tools

Authors Abstract Subjects Details